About Avita Medical, Inc.
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.
2BB score and signals
Avita Medical, Inc.’s current 2BB score is 48 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 71 | High |
| Momentum | 76 | Improving |
| Financial strength | 17 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 52 | Moderate |
Company facts
| CEO | James Corbett |
| Headquarters | Valencia, California, United States |
| Founded | 1999 |
| Employees | 226 |
| 52-week range | $3.22 – $8.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-10 | — | -0.2108 | — | $24.28M |
| 2026-11-05 | — | -0.238 | — | $22.64M |
| 2026-08-06 | — | -0.2924 | — | $20.57M |
| 2026-05-14 | -0.35 | -0.2856 | $19.25M | $18.54M |
Related companies
